US Stock MarketDetailed Quotes

GMAB Genmab

Watchlist
  • 21.020
  • +0.250+1.20%
Trading Dec 31 10:05 ET
13.35BMarket Cap20.83P/E (TTM)

Genmab Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Genmab Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
843.45M
827.54M
-15.90M
Miss Est.
+25.38%
+23.85%
-1.89%
EPS
0.31
0.30
-0.02
Miss Est.
-32.39%
-34.67%
-5.49%
Analyst Rating
Buy

Dec 31, 2024

Genmab Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: DKK

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 4.846B--
--2024/Q4-- / 6.349B--
Nov 6, 20242024/Q35.540B / 5.646B--
Aug 8, 20242024/Q25.402B / 4.959B--
May 2, 20242024/Q14.143B / 3.989B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 4.846B--
--2024/Q4-- / 6.349B--
Nov 6, 20242024/Q35.540B / 5.646B--
Aug 8, 20242024/Q25.402B / 4.959B--
May 2, 20242024/Q14.143B / 3.989B--

Unlock Free Earnings Estimates

Genmab Earnings Reports

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 4 11:32 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 27 13:03 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 6 11:12 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Oct 1 10:35 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Buy

    • Buy

      42.86%

    • Hold

      57.14%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data